Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 4 Breast Neoplasms 2 Obesity 1 Heart Failure 1

Interventions

pegfilgrastim 1 dapagliflozin 1 Vincristine 1 Standard of Care 1 Rituximab 1 Prednisolone 1 Lenalidomide 1 Ivabradine 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Carvedilol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Heart Failure × dapagliflozin × Clear all

NCT06304857 2024-12-04

PROTECTAA

4th Military Clinical Hospital with Polyclinic, Poland

Phase 3 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡